Zai Lab (ZLAB) Stock Price, Quote, News & History | Benzinga

Zai Lab Ltd (ZLAB) Stock Price, Quote, News & History

ZLABNASDAQ

Trade with Public

Trade with Public

$26.08

-0.74-2.76%

At close: Aug 28, 5:00 PM EST

$26.08

N/A

After Hours: Aug 28, 4:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$26.45

Close

$26.08

Volume / Avg.

650.04K / 1.01M

Day Range

$25.87 - $26.45

52 Wk Range

15.96 - 34.72

Market Cap

$2.93B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

65

Short Interest

6.79%

Days to Cover

5.35

Recent Zai Lab Ltd News

UnitedHealth, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were lower this morning, with the Nasdaq futures falling around 100 points on Monday.

Avi Kapoor

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter

Avi Kapoor

FDA Asks Reviva Pharmaceuticals To Conduct Additional Phase 3 Study For Its Schizophrenia Drug

Reviva Pharmaceuticals said the FDA recommended a second Phase 3 trial for its schizophrenia drug brilaroxazine after a pre-NDA meeting.

Vandana Singh

Zai Lab's Double Whammy: Earnings Miss, Phase 3 Setback

Bamboo Works

Amgen Faces Setback As Final Data Weakens Case For Gastric Cancer Drug

Amgen and Zai Lab's Phase 3 trial of bemarituzumab in gastric cancer showed a weaker survival benefit, shifting focus to the upcoming FORTITUDE-102 results.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-133.38M

Investing Cash Flow (TTM)

-39.05M

Financing Cash Flow (TTM)

44.64M

Free Cash Flow (TTM)

-162.52M

Capital Expenditure (TTM)

-29.13M

Net Change in Cash (TTM)

-127.79M

Analyst Trends and Forecast

1

Mar

1

May

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.60B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

6.61

PB Ratio (TTM)

4.96

Earnings Yield % (TTM)

-6.34%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$5.41

Company Debt

Total Debt

$238.10M

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$607.52M

Debt to Equity

0.42

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-$185.99M

Key Statistics

Open

$26.45

Close

$26.08

Volume / Avg.

650.04K / 1.01M

Day Range

$25.87 - $26.45

52 Wk Range

15.96 - 34.72

Market Cap

$2.93B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

65

Short Interest

6.79%

Days to Cover

5.35

About

Sector

Health Care

Industry

Biotechnology

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Zai Lab (ZLAB) stock?

A

You can purchase shares of Zai Lab (NASDAQ:ZLAB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Zai Lab (ZLAB) competitors?

A

Other companies in Zai Lab’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Zai Lab (ZLAB) stock?

A

Zai Lab has a consensus price target of $48.44.

Q

What is the current price for Zai Lab (ZLAB)?

A

The stock price for Zai Lab (NASDAQ: ZLAB) is $26.08 last updated August 28, 2026 at 4:00 PM EDT.

Q

Does Zai Lab (ZLAB) pay a dividend?

A

There are no upcoming dividends for Zai Lab.

Q

When is Zai Lab (NASDAQ:ZLAB) reporting earnings?

A

Zai Lab does not have any upcoming earnings scheduled.

Q

Is Zai Lab (ZLAB) going to split?

A

There is no upcoming split for Zai Lab.

Q

What sector and industry does Zai Lab (ZLAB) operate in?

A

Zai Lab is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.